These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 29743402)
1. [Durable remission attained with rituximab therapy in a patient with acquired von Willebrand syndrome associated with CD20-positive lymphoproliferative disorder]. Kurahashi H; Kawabata Y; Michishita Y; Kitabayashi A; Kobayashi T; Kitadate A; Takahashi N Rinsho Ketsueki; 2018; 59(4):420-425. PubMed ID: 29743402 [TBL] [Abstract][Full Text] [Related]
2. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107 [TBL] [Abstract][Full Text] [Related]
3. Lenalidomide as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy. Lavin M; Brophy TM; Rawley O; O'Sullivan JM; Hayden PJ; Browne PV; Ryan K; O'Connell N; O'Donnell JS J Thromb Haemost; 2016 Jun; 14(6):1200-5. PubMed ID: 26991062 [TBL] [Abstract][Full Text] [Related]
4. Acquired von Willebrand syndrome: an underdiagnosed and misdiagnosed bleeding complication in patients with lymphoproliferative and myeloproliferative disorders. Federici AB Semin Hematol; 2006 Jan; 43(1 Suppl 1):S48-58. PubMed ID: 16427386 [TBL] [Abstract][Full Text] [Related]
5. Acquired von Willebrand syndrome--report of 10 cases and review of the literature. Nitu-Whalley IC; Lee CA Haemophilia; 1999 Sep; 5(5):318-26. PubMed ID: 10583513 [TBL] [Abstract][Full Text] [Related]
6. Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update. Federici AB; Budde U; Castaman G; Rand JH; Tiede A Semin Thromb Hemost; 2013 Mar; 39(2):191-201. PubMed ID: 23397553 [TBL] [Abstract][Full Text] [Related]
7. Association of acquired von Willebrand syndrome with AL amyloidosis. Kos CA; Ward JE; Malek K; Sanchorawala V; Wright DG; O'Hara C; Connors L; Skinner M; Seldin DC Am J Hematol; 2007 May; 82(5):363-7. PubMed ID: 17205535 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of acquired von Willebrand syndrome. Tiede A Thromb Res; 2012 Dec; 130 Suppl 2():S2-6. PubMed ID: 23439003 [TBL] [Abstract][Full Text] [Related]
9. Maintaining hemostasis in acquired von Willebrand syndrome: a review of intravenous immunoglobulin and the importance of rituximab dose scheduling. Kanakry JA; Gladstone DE Transfusion; 2013 Aug; 53(8):1730-5. PubMed ID: 23252513 [TBL] [Abstract][Full Text] [Related]
10. Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome. Federici AB Hum Immunol; 2005 Apr; 66(4):422-30. PubMed ID: 15866707 [TBL] [Abstract][Full Text] [Related]
12. [Acquired von Willebrand syndrome in three patients and literature review]. Ouyang HY; Yu ZJ; Yin J; Zhao XJ; Wang ZY; Zhang W; Ma ZN; Su J; Bai X; Ruan CG Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):692-5. PubMed ID: 27587252 [TBL] [Abstract][Full Text] [Related]
13. Acquired von Willebrand syndrome associated with plasma cell myeloma - a rare histopathological bone marrow image. Chraszczewska M; Sokół K; Kuczkiewicz-Siemion O; Prochorec-Sobieszek M; Szumera-Cieækiewicz A Pol J Pathol; 2019; 70(4):311-316. PubMed ID: 32146801 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic approaches to acquired von Willebrand syndrome. Federici AB Expert Opin Investig Drugs; 2000 Feb; 9(2):347-54. PubMed ID: 11060681 [TBL] [Abstract][Full Text] [Related]